Philip Morris International sells cigarettes outside the United States and smoke-free products: IQOS heated tobacco and ZYN pouches, which arrived with Swedish Match. The American Marlboro cigarette is Altria's, not this company's. ZYN is sold in the United States. Saying PMI has no American risk is false.
Cigarette volume falls. The smoke-free book is what the story calls growth. It is not a monopoly on heated tobacco or on the pouch. A regulator can limit flavours, advertising or the category itself. This report does not state a country count.
The dividend is paid in dollars and has to fit in the cash of both parts, the one that shrinks and the one that grows. This report does not state a yield.
Sustainable Competitive Advantage
"The advantage is the cigarette brand already in place in many countries and the heated-tobacco or pouch system the consumer already uses. Switching device has friction. It is not a patent that closes the category. The moat narrows if the rule cuts the new product, or if the cigarette falls by more than the other book grows."
Loading the Vaultflake…
Radar axes
—
Health
—
Moat
—
Growth
—
Value
—
Return
—
Health is the cash of the two portfolios. Looking fine because of the dividend can hide that one leg is shrinking. Quality separates the cigarette margin from IQOS and ZYN. Growth is the smoke-free book, not pack volume. P/E valuation is read against that mix, not against a cigarette-only year. Shareholder return is the dollar dividend, crossed with what the rule still allows to be sold.
The group's P/E mixes a business that falls and one that grows. EV/EBITDA of a ZYN year is not the normal earnings of the cigarette. The dollar dividend is not a yield this report fixes. Do not use Altria's multiple as if the map were the same. A dash means the PM cache is cold.
Limits of this report
Not advice on PM. Vaultflake does not forecast a pouch rule or an IQOS share. This is not a country map. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Questions from this report
What moat does Philip Morris International have?
The advantage is the cigarette brand already in place in many countries and the heated-tobacco or pouch system the consumer already uses. Switching device has friction. It is not a patent that closes the category. The moat narrows if the rule cuts the new product, or if the cigarette falls by more than the other book grows.
How do you read the Philip Morris International radar?
Health is the cash of the two portfolios. Looking fine because of the dividend can hide that one leg is shrinking. Quality separates the cigarette margin from IQOS and ZYN. Growth is the smoke-free book, not pack volume. P/E valuation is read against that mix, not against a cigarette-only year. Shareholder return is the dollar dividend, crossed with what the rule still allows to be sold.
Which multiples matter for Philip Morris International?
The group's P/E mixes a business that falls and one that grows. EV/EBITDA of a ZYN year is not the normal earnings of the cigarette. The dollar dividend is not a yield this report fixes. Do not use Altria's multiple as if the map were the same. A dash means the PM cache is cold.
What does this Philip Morris International analysis leave out?
Not advice on PM. Vaultflake does not forecast a pouch rule or an IQOS share. This is not a country map. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Related reports in Consumer Staples · Cigarettes and Smoke-free
